BACK

DRAP without CEO for two weeks, regulatory affairs in limbo

M. Waqar Bhatti
Sunday, Feb 16, 2025

ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has been operating without a Chief Executive Officer (CEO) for the past two weeks, as the government has yet to extend the tenure of Asim Rauf or appoint a successor.

The lack of leadership at the country’s top drug regulatory body has raised concerns over delays in crucial pharmaceutical and medical regulatory affairs.

“At present, DRAP is functioning without a CEO following the completion of Asim Rauf’s tenure. The Ministry of National Health Services, Regulations and Coordination (NHS, R&C) has forwarded a summary to the Prime Minister’s office,” a senior official of the health ministry told The News.

The official further revealed that after Asim Rauf’s departure, an interview committee led by Dr Azhar Mahmood Kayani and comprising seven other members interviewed four shortlisted candidates for the CEO.

“In the meantime, DRAP’s Policy Board has recommended a three-month extension for Asim Rauf, allowing continuity in leadership until a permanent CEO is appointed,” the official added. Officials at the health ministry remain hopeful that a decision will be made by Monday.

DRAP officials have expressed growing concerns over the adverse impact of the leadership vacuum on the day-to-day operations.